September 23, 2021
Q3 2021
Summary and Key Findings:
  • 98 samples were reported between April and August 2021
  • Most “heroin” samples contained fentanyl cut with xylazine; however, heroin was identified in the supply without fentanyl
  • Cocaine and methamphetamine samples were not adulterated; fentanyl contamination was not observed in this sample set*
  • para-Fluorofentanyl continues increasing in prevalence, being identified as the primary opioid in some “heroin” samples
  • Counterfeit “Xanax” found to contain NPS benzodiazepines